NASDAQ:INGNInogen Stock Price, Forecast & News

Inogen's stock was trading at $40.61 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, INGN shares have decreased by 10.7% and is now trading at $36.27. View which stocks have been most impacted by Coronavirus.

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Inogen in the last year. There are currently 1 sell rating, 4 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Inogen.

Inogen is scheduled to release its next quarterly earnings announcement on Wednesday, August 5th 2020. View our earnings forecast for Inogen.

Inogen Inc (NASDAQ:INGN) announced its earnings results on Tuesday, May, 5th. The medical technology company reported ($0.07) EPS for the quarter, topping analysts' consensus estimates of ($0.11) by $0.04. The medical technology company earned $88.49 million during the quarter, compared to analyst estimates of $82.33 million. Inogen had a net margin of 3.90% and a return on equity of 4.93%. Inogen's quarterly revenue was down 1.9% on a year-over-year basis. During the same period last year, the firm earned $0.24 earnings per share. View Inogen's earnings history.

7 brokerages have issued 12-month price objectives for Inogen's stock. Their forecasts range from $45.00 to $80.00. On average, they expect Inogen's share price to reach $60.80 in the next year. This suggests a possible upside of 67.6% from the stock's current price. View analysts' price targets for Inogen.

Media headlines about INGN stock have trended negative this week, InfoTrie Sentiment Analysis reports. The research firm ranks the sentiment of press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Inogen earned a daily sentiment score of -2.2 on InfoTrie's scale. They also gave media stories about the medical technology company a news buzz of 5.0 out of 10, meaning that recent press coverage is somewhat likely to have an effect on the company's share price in the near term. View the latest news about Inogen.

Inogen saw a decline in short interest in the month of June. As of June 15th, there was short interest totaling 2,830,000 shares, a decline of 6.0% from the May 31st total of 3,010,000 shares. Based on an average trading volume of 427,500 shares, the days-to-cover ratio is presently 6.6 days. Approximately 15.5% of the company's shares are sold short. View Inogen's Current Options Chain.

Some companies that are related to Inogen include Wound Management Technologies (WNDM), Avanos Medical (AVNS), Establishment Labs (ESTA), Invacare (IVC), RTI Surgical (RTIX), Sientra (SIEN), Lakeland Industries (LAKE), COLLPLANT HOLDI/S (CLGN), ConforMIS (CFMS), Allied Healthcare Products (AHPI), Histogenics (HSGX), Rewalk Robotics (RWLK), Precision Therapeutics (POAI), Ocugen (OCGN) and NanoVibronix (NAOV). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Inogen investors own include Puma Biotechnology (PBYI), BioMarin Pharmaceutical (BMRN), Incyte (INCY), Medivation (MDVN), NVIDIA (NVDA), Alibaba Group (BABA), First Solar (FSLR), Netflix (NFLX), Intel (INTC) and Advanced Micro Devices (AMD).

Inogen trades on the NASDAQ under the ticker symbol "INGN."

Shares of INGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of INGN stock can currently be purchased for approximately $36.27.

Inogen has a market capitalization of $799.75 million and generates $361.94 million in revenue each year. The medical technology company earns $20.95 million in net income (profit) each year or $1.07 on an earnings per share basis. Inogen employs 1,020 workers across the globe.

The official website for Inogen is www.inogen.com.

Inogen's mailing address is 326 BOLLAY DRIVE, GOLETA CA, 93117. The medical technology company can be reached via phone at 805-562-0500 or via email at [email protected]